Tumour cells poison themselves when consuming an Omega-3 fatty acid due to an inability to store it correctly, a study claims, which proposes this mechanism to explain the fatty acid’s cancer-fighting abilities.
‘Designer’ biotherapeutics rationally designed to address the dysbiotic microbiome seen in Crohn’s disease and ulcerative colitis may be the ‘breakthrough’ researchers are looking for in tackling these conditions.
Gut health. It’s everywhere. It’s hard not to go a day without hearing about the microbiome or the launch of a new probiotic. But the more we learn about this enigma within us, the more questions arise.
Supplementation with a novel bacterium isolated from the human gut may counteract diet-induced obesity, insulin resistance, and inflammation, says a new study that creates “an incredible scientific opportunity”.
Using a nanocarrier delivery system, the olive oil-derived extract Hydroxytyrosol can act as a protective agent against Parkinson’s-related neurodegeneration, according to a new study from the Centre for Nutraceuticals, University of Westminster.
Consumers suffering from chronic diseases or cancer could be vulnerable to the empty promises and misleading health claims, which is why Dr Janet Schloss, the latest guest on our NutraChampion podcast, has made it her mission to drive an evidence-based...